PLoS ONE (Jan 2014)

Galectin-9 enhances cytokine secretion, but suppresses survival and degranulation, in human mast cell line.

  • Reiji Kojima,
  • Tatsukuni Ohno,
  • Motoyasu Iikura,
  • Toshiro Niki,
  • Mitsuomi Hirashima,
  • Keichi Iwaya,
  • Hitoshi Tsuda,
  • Shigeaki Nonoyama,
  • Akio Matsuda,
  • Hirohisa Saito,
  • Kenji Matsumoto,
  • Susumu Nakae

DOI
https://doi.org/10.1371/journal.pone.0086106
Journal volume & issue
Vol. 9, no. 1
p. e86106

Abstract

Read online

Galectin-9 (Gal-9), a lectin having a β-galactoside-binding domain, can induce apoptosis of Th1 cells by binding to TIM-3. In addition, Gal-9 inhibits IgE/Ag-mediated degranulation of mast cell/basophilic cell lines by binding to IgE, thus blocking IgE/Ag complex formation. However, the role of Gal-9 in mast cell function in the absence of IgE is not fully understood. Here, we found that recombinant Gal-9 directly induced phosphorylation of Erk1/2 but not p38 MAPK in a human mast cell line, HMC-1, which does not express FcεRI. Gal-9 induced apoptosis and inhibited PMA/ionomycin-mediated degranulation of HMC-1 cells. On the other hand, Gal-9 induced cytokine and/or chemokine production by HMC-1 cells, dependent on activation of ERK1/2 but not p38 MAPK. In addition, the lectin activity of Gal-9 was required for Gal-9-mediated cytokine secretion by HMC-1 cells. These observations suggest that Gal-9 has dual properties as both a regulator and an activator of mast cells.